MyLungCancerTeam

What is the prognosis for stage 2B non-small cell lung cancer?

Stage 2B non-small cell lung cancer has a moderate outlook. The five-year survival rate for stage 2 NSCLC is around 35 percent, meaning about 35 out of 100 people are still alive five years after diagnosis.

Several factors can influence your individual outcome Show Full Answer

What is the prognosis for stage 2B non-small cell lung cancer?

Stage 2B non-small cell lung cancer has a moderate outlook. The five-year survival rate for stage 2 NSCLC is around 35 percent, meaning about 35 out of 100 people are still alive five years after diagnosis.

Several factors can influence your individual outcome beyond just the stage:

- The size of the tumor
- The type of treatment you receive
- How well your body responds to therapy
- Your overall health

In stage 2B, the tumor may be up to 7 centimeters, blocking part of the airways, pressing on the chest wall, or growing into the main bronchus. It may also be smaller but has spread to nearby lymph nodes.

Treatment typically includes surgery (often a lobectomy) followed by chemotherapy to kill any remaining cancer cells. Immunotherapy may also be recommended to help your immune system fight the cancer more effectively.

If surgery isn't an option due to overall health concerns, other treatments like radiation therapy, chemotherapy, immunotherapy, or targeted therapy may be used instead, sometimes in combination.

Thanks to advances in treatment, outcomes continue to improve for people with stage 2 NSCLC.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

NSCLC Staging: Symptoms, Treatments, and More